Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.14 USD | -2.56% | -8.06% | -64.81% |
May. 21 | Hepion Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 22 | Sector Update: Health Care Stocks Increase Late Afternoon | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 6.4M |
---|---|---|---|---|---|
Net income 2024 * | -51M | Net income 2025 * | -76M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.1
x | P/E ratio 2025 * |
-
| Employees | 22 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.69% |
1 day | -2.56% | ||
1 week | -0.87% | ||
Current month | -16.48% | ||
1 month | -19.15% | ||
3 months | -53.47% | ||
6 months | -61.87% | ||
Current year | -64.81% |
Managers | Title | Age | Since |
---|---|---|---|
John Cavan
CEO | Chief Executive Officer | 65 | 15-12-31 |
Daren Ure
CTO | Chief Tech/Sci/R&D Officer | - | 19-10-02 |
Stephen Kilmer
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
John Brancaccio
CHM | Chairman | 76 | 13-05-14 |
Timothy Block
BRD | Director/Board Member | 69 | 13-11-25 |
Kaouthar Lbiati
BRD | Director/Board Member | 45 | 22-06-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 1.14 | -2.56% | 18,291 |
24-05-22 | 1.17 | 0.00% | 28,809 |
24-05-21 | 1.17 | 0.00% | 17,694 |
24-05-20 | 1.17 | -10.00% | 33,427 |
24-05-17 | 1.3 | +4.84% | 28,651 |
Delayed Quote Nasdaq, May 23, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-64.81% | 6.4M | |
+10.79% | 115B | |
+11.65% | 106B | |
-6.20% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.41% | 17.56B | |
-40.50% | 17.32B | |
+6.64% | 14.03B | |
+31.84% | 12.13B |
- Stock Market
- Equities
- HEPA Stock